0001638599-20-000912.txt : 20201123 0001638599-20-000912.hdr.sgml : 20201123 20201123160528 ACCESSION NUMBER: 0001638599-20-000912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201119 FILED AS OF DATE: 20201123 DATE AS OF CHANGE: 20201123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GANDOLFO JOHN P CENTRAL INDEX KEY: 0001200155 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38365 FILM NUMBER: 201337263 MAIL ADDRESS: STREET 1: 62 TERRACE ROAD CITY: WAYNE STATE: NJ ZIP: 07470 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYENOVIA, INC. CENTRAL INDEX KEY: 0001682639 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471178401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 813-766-9539 MAIL ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4_6927.xml PRIMARY DOCUMENT X0306 4 2020-11-19 0 0001682639 EYENOVIA, INC. EYEN 0001200155 GANDOLFO JOHN P C/O EYENOVIA, INC. 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 0 1 0 0 Chief Financial Officer Common Stock, par value $.0001 2020-11-19 4 P 0 4000 3.40 A 6000 D Stock Option (right to buy) 2.72 2030-06-02 Common Stock 114774 114774 D Stock Option (right to buy) 8.72 2028-04-16 Common Stock 71200 71200 D Stock Option (right to buy) 6.20 2028-07-24 Common Stock 24842 24842 D Stock Option (right to buy) 3.11 2029-08-16 Common Stock 53402 53402 D One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. The option became exercisable as to 1,977 shares on May 16, 2018 and becomes exercisable in equal 1,977 share amounts on each of the 35 one-month anniversaries thereafter. One-third of the option became exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. One-third of the option became exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. /s/ S. Halle Vakani, Attorney-in-Fact 2020-11-23